These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 30698552)
1. [Lacosamide in treatment of patients with focal epilepsy and comorbid mental disorders]. Yakovleva YA; Yanaeva AN; Spikina AA; Rukavitsyna EL Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(10. Vyp. 2):98-104. PubMed ID: 30698552 [TBL] [Abstract][Full Text] [Related]
2. [Lacosamide (vimpat). Prospects for clinical application]. Rudakova IG; Vlasov PN; Lipatova LV; Voronkova KV Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):147-152. PubMed ID: 29053136 [TBL] [Abstract][Full Text] [Related]
3. Lacosamide in monotherapy in BTRE (brain tumor-related epilepsy): results from an Italian multicenter retrospective study. Mo F; Meletti S; Belcastro V; Quadri S; Napolitano M; Bello L; Dainese F; Scarpelli M; Florindo I; Mascia A; Pauletto G; Bruno F; Pellerino A; Giovannini G; Polosa M; Sessa M; Conti Nibali M; Di Gennaro G; Gigli GL; Pisanello A; Cavallieri F; Rudà R J Neurooncol; 2022 May; 157(3):551-559. PubMed ID: 35397759 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs. Neal A; D'Souza W; Hepworth G; Lawn N; Cook M; Nikpour A Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359 [TBL] [Abstract][Full Text] [Related]
6. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group. Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754 [TBL] [Abstract][Full Text] [Related]
7. Long-term exposure and safety of lacosamide monotherapy for the treatment of partial-onset (focal) seizures: Results from a multicenter, open-label trial. Vossler DG; Wechsler RT; Williams P; Byrnes W; Therriault S; Epilepsia; 2016 Oct; 57(10):1625-1633. PubMed ID: 27528101 [TBL] [Abstract][Full Text] [Related]
8. Lacosamide efficacy and tolerability in clinical practice - Post marketing analysis from a single dedicated epilepsy center. Baker MD; Abou-Khalil BW; Arain A; Tummala P; Azar NJ; Haas KF; Sonmezturk HH Clin Neurol Neurosurg; 2018 Aug; 171():179-183. PubMed ID: 29929174 [TBL] [Abstract][Full Text] [Related]
9. LACONORTE study: Efficacy and security of lacosamide as first add-on therapy for focal-onset epilepsy in real-life setting. Muñoz-Lopetegi A; López-González FJ; Rodríguez-Osorio X; Pato Pato A; Bellas Lamas P; Abella-Corral J; Castro Vilanova MD; Garea MJ; Gil López JA; Ruiz-Martínez J; Poza JJ Epilepsy Res; 2018 Sep; 145():51-54. PubMed ID: 29890341 [TBL] [Abstract][Full Text] [Related]
10. Lacosamide treatment of childhood refractory focal epilepsy: the first reported side effect in paediatric patients. Yildiz EP; Ozkan MU; Bektas G; Uzunhan TA; Aydinli N; Caliskan M; Ozmen M Childs Nerv Syst; 2017 Nov; 33(11):2023-2027. PubMed ID: 28884208 [TBL] [Abstract][Full Text] [Related]
11. Lacosamide as first add-on or conversion monotherapy: A retrospective real-life study. Casciato S; Quarato PP; Gialluisi A; D'Aniello A; Mascia A; Grammaldo LG; Di Gennaro G Epilepsy Behav; 2021 Sep; 122():108128. PubMed ID: 34229159 [TBL] [Abstract][Full Text] [Related]
12. Outcomes following exposure to lacosamide monotherapy during pregnancy and breastfeeding - a prospective case series. Bosak M; Dziedzic R; Matwiej K; Słowik A Neurol Neurochir Pol; 2024; 58(2):203-206. PubMed ID: 38305480 [TBL] [Abstract][Full Text] [Related]
13. Effect of lacosamide on depression and anxiety symptoms in patients with focal refractory epilepsy: A prospective multicenter study. Rocamora R; Ley M; Molins A; Toledo M; Sansa G; Bertol V; Becerra JL; Carreño M; Mauri JÁ Epilepsy Behav; 2018 Feb; 79():87-92. PubMed ID: 29253680 [TBL] [Abstract][Full Text] [Related]
14. Long-term efficacy and safety of lacosamide monotherapy in the treatment of partial-onset seizures: A multicenter evaluation. Giráldez BG; Toledano R; García-Morales I; Gil-Nagel A; López-González FJ; Tortosa D; Ojeda J; Serratosa JM Seizure; 2015 Jul; 29():119-22. PubMed ID: 26076854 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of treatment with lacosamide: Postmarketing experience from the Middle East region. Arabi M; Alsaadi T; Nasreddine W; Al-Hashel J; Dirani M; Beydoun A Epilepsy Behav; 2018 Jul; 84():118-121. PubMed ID: 29778846 [TBL] [Abstract][Full Text] [Related]
16. Status epilepticus developing during lacosamide monotherapy. Papacostas SS BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25628098 [TBL] [Abstract][Full Text] [Related]
17. A common reference-based indirect comparison meta-analysis of eslicarbazepine versus lacosamide as add on treatments for focal epilepsy. Brigo F; Trinka E; Bragazzi NL; Nardone R; Milan A; Grillo E Epilepsy Res; 2016 Nov; 127():12-18. PubMed ID: 27543806 [TBL] [Abstract][Full Text] [Related]
18. Safety, efficacy, and tolerability of lacosamide for the treatment of epilepsy in pediatric patients in Uygur, China. Zhao T; Li HJ; Ma L; Feng J; Wang TT; Yu J; Sun L; Sun Y; Yu LH Epilepsy Behav; 2021 Apr; 117():107814. PubMed ID: 33611102 [TBL] [Abstract][Full Text] [Related]
19. Early clinical experience with lacosamide as adjunctive therapy in patients with refractory focal epilepsy and nocturnal seizures. García-Morales I; Delgado RT; Falip M; Campos D; García ME; Gil-Nagel A Seizure; 2011 Dec; 20(10):801-4. PubMed ID: 21917484 [TBL] [Abstract][Full Text] [Related]
20. Lacosamide tolerability in adult patients with partial-onset seizures: Impact of planned reduction and mechanism of action of concomitant antiepileptic drugs. Foldvary-Schaefer N; Fong JS; Morrison S; Wang L; Bena J Epilepsy Behav; 2016 Apr; 57(Pt A):155-160. PubMed ID: 26956629 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]